Compositions And Methods For Lowering Levels Of High-sensitivity C-reactive Protein (hs-crp) In A Subject


The present disclosure provides methods for treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In some embodiments, the method comprises lowering high sensitivity CRP (hs-CRP) levels in a subject including, for example, a subject with a HbA1c value of about 5.00 %-8.50 % or at least about 6.8 %.

Download PDF
Document Preview
Document History
  • Publication: Nov 28, 2017
  • Application: Jan 7, 2013
    US US 201313735660 A
  • Priority: Jan 7, 2013
    US US 201313735660 A
  • Priority: Jul 11, 2012
    US US 201261670408 P
  • Priority: Jun 6, 2012
    US US 201261656347 P
  • Priority: Jan 6, 2012
    US US 201261584013 P

Download Citation

Sign in to the Lens